financetom
Business
financetom
/
Business
/
Global Self Storage Extends $15 Million Revolver
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global Self Storage Extends $15 Million Revolver
Jul 11, 2024 3:03 PM

05:31 PM EDT, 07/11/2024 (MT Newswires) -- Global Self Storage ( SELF ) said late Thursday it extended its $15 million revolving credit facility with Huntington National Bank for another three years.

The real estate investment trust said it will then have the option to extend the revolver by another year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Soccer-Sesko double but Man United held to 2-2 draw at lowly Burnley
Soccer-Sesko double but Man United held to 2-2 draw at lowly Burnley
Mar 10, 2026
BURNLEY, England, Jan 7 (Reuters) - Manchester United's ( MANU ) Benjamin Sesko scored twice as his team kicked off the post-Ruben Amorim era with a familiar sense of frustration in a ‌2-2 Premier League draw at lowly Burnley on Wednesday. United, with interim ​manager Darren Fletcher in charge, would have climbed ‍to fourth in the table with ⁠a win...
Market Chatter: AbbVie in Advanced Talks to Acquire Revolution Medicines
Market Chatter: AbbVie in Advanced Talks to Acquire Revolution Medicines
Mar 10, 2026
03:01 PM EST, 01/07/2026 (MT Newswires) -- AbbVie ( ABBV ) is nearing a deal to acquire cancer-drug biotech company Revolution Medicines ( RVMD ) , The Wall Street Journal reported Wednesday, citing people familiar with the matter. Financial terms of a potential deal couldn't be learned, but Revolution could be valued at around $20 billion at a minimum, according...
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy
Mar 10, 2026
By Puyaan Singh Jan 7 (Reuters) - Eli Lilly ( LLY ) will buy autoimmune drug developer Ventyx Biosciences ( VTYX ) for $1.2 billion in cash, the companies said on Wednesday, marking the Zepbound maker's latest push to expand beyond its ‌blockbuster diabetes and weight-loss drugs. Ventyx is developing several treatments, including oral therapies ​for inflammatory bowel diseases such...
AbbVie in talks to buy biotech Revolution Medicines, WSJ reports
AbbVie in talks to buy biotech Revolution Medicines, WSJ reports
Mar 10, 2026
Jan 7 (Reuters) - AbbVie ( ABBV ) is in advanced talks to buy cancer-drug developer Revolution Medicines ( RVMD ), the Wall Street Journal reported on ‌Wednesday, citing people familiar with the matter. Shares ​of Revolution were up nearly ‍30% after the report. AbbVie's ( ABBV ) ⁠stock ⁠was up more than 5%. The potential deal could ‌be the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved